Marija Balic

Hematology Oncology | Hematology | Oncology

200 Lothrop St
Pittsburgh, PA 15213

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 119 publications

Personalized whole-genome-based ctDNA dynamics during neoadjuvant therapy across breast cancer subtypes: results from MONITOR-Breast.

Personalized whole-genome-based ctDNA dynamics during neoadjuvant therapy across breast cancer subtypes: results from MONITOR-Breast.

Journal: Future oncology (London, England)

Published: June 22, 2026

Quantitative and qualitative patient-reported analysis of misdiagnosis and/or late diagnosis of metastatic lobular cancer.

Quantitative and qualitative patient-reported analysis of misdiagnosis and/or late diagnosis of metastatic lobular cancer.

Journal: medRxiv : the preprint server for health sciences

Published: May 04, 2026

The Xpert Breast Cancer Insight Test Predicts Distant Recurrence and Overall Survival in ER-Positive, HER2-Negative Early Breast Cancer.

The Xpert Breast Cancer Insight Test Predicts Distant Recurrence and Overall Survival in ER-Positive, HER2-Negative Early Breast Cancer.

Journal: Clinical breast cancer

Published: April 01, 2026

Common analysis pitfalls in longitudinal ctDNA studies: lead time, sensitivity and immortal time bias.

Common analysis pitfalls in longitudinal ctDNA studies: lead time, sensitivity and immortal time bias.

Journal: EBioMedicine

Published: March 04, 2026

A novel algae oil-based emulsion enhances chemotherapy outcome in human cancer models.

A novel algae oil-based emulsion enhances chemotherapy outcome in human cancer models.

Journal: Prostaglandins, leukotrienes, and essential fatty acids

Published: February 10, 2026

Integrating baseline ctDNA-derived tumor metrics enhances risk stratification in HR-positive/HER2-negative advanced breast cancer: a real-world multicenter cohort study from Austria.

Integrating baseline ctDNA-derived tumor metrics enhances risk stratification in HR-positive/HER2-negative advanced breast cancer: a real-world multicenter cohort study from Austria.

Journal: ESMO open

Published: November 21, 2025

Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies.

Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 24, 2025

Magee Equation 3 demonstrates predictive and prognostic value for neoadjuvant chemotherapy outcomes in estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer.

Magee Equation 3 demonstrates predictive and prognostic value for neoadjuvant chemotherapy outcomes in estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer.

Journal: American journal of clinical pathology

Published: October 08, 2025

Interim Analysis of Dose-Escalated Preoperative Breast Irradiation: A Phase Ib study.

Interim Analysis of Dose-Escalated Preoperative Breast Irradiation: A Phase Ib study.

Journal: medRxiv : the preprint server for health sciences

Published: September 15, 2025

Longitudinal ctDNA Surveillance in Older Women with ER+ Breast Cancer to Facilitate Surgical De-Escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies.

Longitudinal ctDNA Surveillance in Older Women with ER+ Breast Cancer to Facilitate Surgical De-Escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies.

Journal: medRxiv : the preprint server for health sciences

Published: September 02, 2025

Long-term prognostic value of ctDNA in early breast cancer: insights from the neoadjuvant ABCSG-34 Trial.

Long-term prognostic value of ctDNA in early breast cancer: insights from the neoadjuvant ABCSG-34 Trial.

Journal: NPJ breast cancer

Published: July 28, 2025

Clinical and histopathological characterization of metastatic lobular breast cancer: lessons learned from post-mortem tissue donation programs.

Clinical and histopathological characterization of metastatic lobular breast cancer: lessons learned from post-mortem tissue donation programs.

Journal: NPJ breast cancer

Published: June 30, 2025

Showing 1-12 of 119

Last Updated: 09/26/2026